Intrduction: The trigeminal nerve — the fifth cranial nerve — is responsible for facial sensation and the motor control of the chewing muscles. When a brain tumor grows to a sufficient size, it may directly compress or infiltrate the trigeminal nerve, producing a characteristic constellation of symptoms. According to the Chinese Guidelines for the Diagnosis and Treatment of Central Nervous System Tumors (2023 Edition), approximately 12–18% of intracranial tumor patients develop trigeminal nerve involvement, with tumors of the cerebellopontine angle, sellar region, and skull base being the most common culprits. Early recognition of these symptoms and timely targeted intervention are critical to improving patient outcomes.

Anatomy of the Trigeminal Nerve and Mechanisms of Compression

The trigeminal nerve comprises three branches — the ophthalmic, maxillary, and mandibular divisions — responsible for sensory transmission from the periorbital region, the mid-face, and the lower jaw respectively. The nerve root emerges from the ventrolateral surface of the pons and travels through a series of complex anatomical structures, including Meckel's cave and the cavernous sinus. This extended course makes it vulnerable to tumor compression at multiple points along the way.

The mechanisms by which brain tumors compress the trigeminal nerve are twofold: direct mechanical compression and secondary inflammatory responses. When tumor volume exceeds 4 cm³, it can exert a compressive force of approximately 30–50 mmHg — sufficient to disrupt nerve conduction. Simultaneously, inflammatory mediators released by the tumor, such as IL-6 and TNF-α, further aggravate nerve edema, creating a self-reinforcing cycle of injury.

Clinical Symptoms

Pain

The most prominent symptom of trigeminal nerve compression is severe pain — typically unilateral, with a lightning-bolt or stabbing quality. Pain intensity commonly reaches 8–10 on the Visual Analogue Scale (VAS), with individual episodes lasting anywhere from seconds to minutes. Unlike primary trigeminal neuralgia, pain caused by tumor compression tends to follow a progressively worsening course and responds poorly to medication.

Sensory Disturbance

Patients may experience facial numbness, sensory loss, or abnormal sensations. Depending on which branch of the nerve is compressed, symptoms can be localized to specific regions: ophthalmic branch involvement produces sensory disturbance in the forehead; maxillary branch involvement affects the mid-face; and mandibular branch involvement leads to sensory dysfunction around the lower jaw and oral cavity. Approximately 65% of patients show diminished corneal reflexes.

Motor Dysfunction

Compression of the motor root of the trigeminal nerve can cause weakness of the chewing muscles and jaw deviation. In severe cases, atrophy of the temporalis and masseter muscles develops, impairing normal eating function. These findings typically indicate a larger tumor or prolonged compression.

Associated Symptoms

Most patients also experience headache and dizziness consistent with raised intracranial pressure. If the tumor invades adjacent nerves, facial palsy or hearing loss may develop. Notably, approximately 25% of patients present with trigeminal symptoms as their initial complaint, with other neurological signs appearing only later.

Diagnosis

Imaging

MRI is the first-line diagnostic modality. The 3D time-of-flight (3D-TOF) sequence is particularly valuable for visualizing the anatomical relationship between the tumor and the trigeminal nerve. In accordance with the Chinese Expert Consensus on Brain Tumor Imaging Diagnosis (2022 Edition), 1 mm thin-slice scanning is recommended to maximize detection sensitivity. CT scanning provides complementary information regarding bony destruction.

Neurological Function Assessment

A thorough neurological examination should include testing of the corneal reflex and masticatory muscle strength. Quantitative sensory testing (QST) enables objective measurement of the degree of sensory impairment. Neurophysiological studies — including the blink reflex — help localize the level of the lesion.

Differential Diagnosis

The condition must be distinguished from primary trigeminal neuralgia and odontogenic (dental) pain, among others. Tumor-related compression typically follows a progressive course and is usually accompanied by other neurological signs. Pain from vascular causes tends to respond well to carbamazepine, whereas tumor-related pain responds poorly to pharmacological treatment.

Treatment

Surgery

Tumor resection is the definitive means of relieving nerve compression. The surgical approach is selected according to tumor location: the subtemporal approach is appropriate for middle cranial fossa tumors, while the retrosigmoid approach is preferred for cerebellopontine angle lesions. The operative goal is maximum safe tumor removal with preservation of critical neurological function.

Radiation Therapy

For patients who are high surgical risks, or in cases of residual tumor following surgery, radiation therapy is an important option. Stereotactic radiosurgery — such as Gamma Knife — enables precise targeting while sparing surrounding critical structures. Available data indicate that pain relief rates following radiosurgery reach 60–75%.

Pharmacological Management

Antiepileptic drugs such as carbamazepine and gabapentin can be used for symptomatic control, though it must be emphasized that these agents do not treat the underlying tumor. Nerve blocks and other symptomatic measures may be employed during acute pain episodes.

Prognosis and Rehabilitation

Prognosis depends on tumor type, duration of compression, and timing of treatment. For benign tumors, complete resection achieves symptom relief in over 80% of patients; malignant tumors require a comprehensive multimodal approach. During the rehabilitation period, attention should be directed toward facial sensory function training, with regular follow-up to assess the degree of neurological recovery.

Frequently Asked Questions

What symptoms does trigeminal nerve compression from a brain tumor cause?

Typical symptoms include severe unilateral facial pain, sensory loss or abnormal sensations, and possible weakness of the chewing muscles. Symptoms tend to worsen progressively over time and respond less well to medication than primary trigeminal neuralgia.

How painful is trigeminal neuralgia?

Pain intensity can reach 8–10 on the VAS scale, described by patients as an electric shock or tearing sensation. Episodes can interfere with eating, speaking, and other daily activities. It is widely recognized as one of the most severe pain conditions known to medicine.

Is surgery for trigeminal nerve compression from a brain tumor technically difficult?

Surgical difficulty depends on the tumor's location, size, and relationship to surrounding structures. Modern microneurosurgical techniques have substantially improved operative safety, but the procedure still requires an experienced team. The majority of patients achieve meaningful symptom improvement following surgery.

Reference: https://www.incsg.com/sanchaqiaoliu/6942.html